Literature DB >> 12437397

The underlying risk of death after myocardial infarction in the absence of treatment.

Malcolm R Law1, Hilary C Watt, Nicholas J Wald.   

Abstract

BACKGROUND: The underlying risk of death in the absence of treatment after a myocardial infarction (MI) is poorly documented.
METHODS: Analysis of 23 published studies in which 14 211 patients were followed prospectively after MI; 6817 deaths were recorded. We restricted the analysis to studies in which follow-up was completed by 1980 to quantify the underlying risk in the absence of effective treatments.
RESULTS: After a first MI, on average, 23% of patients died before reaching the hospital and another 13% died during hospital admission; these rates increased with age. After hospital discharge cardiovascular mortality was approximately 10% in the first year and 5% per year thereafter, rates that were unrelated to age or sex. The yearly death rate of 5% persisted indefinitely; after 15 years, cumulative cardiovascular mortality was 70%. After a subsequent MI, 33% of patients died before reaching the hospital, and 20% died in hospital. After discharge, cardiovascular mortality was approximately 20% in the first year and 10% per year thereafter, rates again unrelated to age and sex. Approximately a third of all heart disease deaths occurred minutes after the first MI, a sixth during the first hospitalization, and half after a subsequent MI, which could occur many years after the first.
CONCLUSIONS: In persons with a history of MI, cardiovascular mortality in the absence of treatment is high-5% per year after a first MI and 10% per year after a subsequent MI, persisting for many years and probably for the rest of a person's life. The high mortality rate emphasizes the need to ensure that everyone who has had an MI, even years previously, receives effective preventive treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12437397     DOI: 10.1001/archinte.162.21.2405

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  61 in total

Review 1.  Risk factor thresholds: their existence under scrutiny.

Authors:  M R Law; N J Wald
Journal:  BMJ       Date:  2002-06-29

2.  Costs and benefits of free medications after myocardial infarction.

Authors:  Irfan A Dhalla; Monique A Smith; Niteesh K Choudhry; Avram E Denburg
Journal:  Healthc Policy       Date:  2009-11

3.  Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.

Authors:  Jacqueline Neuhaus; Brian Angus; Justyna D Kowalska; Alberto La Rosa; Jim Sampson; Deborah Wentworth; Amanda Mocroft
Journal:  AIDS       Date:  2010-03-13       Impact factor: 4.177

4.  Referral to and discharge from cardiac rehabilitation: key informant views on continuity of care.

Authors:  Sherry L Grace; Suzan Krepostman; Dina Brooks; Susan Jaglal; Beth L Abramson; Pat Scholey; Neville Suskin; Heather Arthur; Donna E Stewart
Journal:  J Eval Clin Pract       Date:  2006-04       Impact factor: 2.431

5.  Epidemiology of cardioprotective pharmacological agent use in stable coronary heart disease.

Authors:  Krishna Kumar Sharma; Mukul Mathur; Rakesh Gupta; Soneil Guptha; Sanjeeb Roy; R S Khedar; Nishant Gupta; Rajeev Gupta
Journal:  Indian Heart J       Date:  2013-04-09

6.  Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines.

Authors:  Renee Stark; Inge Kirchberger; Matthias Hunger; Margit Heier; Reiner Leidl; Wolfgang von Scheidt; Christa Meisinger; Rolf Holle
Journal:  Clin Res Cardiol       Date:  2013-11-28       Impact factor: 5.460

7.  Transcriptome from circulating cells suggests dysregulated pathways associated with long-term recurrent events following first-time myocardial infarction.

Authors:  Rahul Suresh; Xing Li; Anca Chiriac; Kashish Goel; Andre Terzic; Carmen Perez-Terzic; Timothy J Nelson
Journal:  J Mol Cell Cardiol       Date:  2014-05-04       Impact factor: 5.000

8.  Pre-hospital ECG for acute coronary syndrome in urban India: a cost-effectiveness analysis.

Authors:  Joshua Schulman-Marcus; Dorairaj Prabhakaran; Thomas A Gaziano
Journal:  BMC Cardiovasc Disord       Date:  2010-03-12       Impact factor: 2.298

9.  Quality of systematic reviews of observational nontherapeutic studies.

Authors:  Tatyana Shamliyan; Robert L Kane; Stacy Jansen
Journal:  Prev Chronic Dis       Date:  2010-10-15       Impact factor: 2.830

Review 10.  Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis.

Authors:  Hasnain M Dalal; Anna Zawada; Kate Jolly; Tiffany Moxham; Rod S Taylor
Journal:  BMJ       Date:  2010-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.